<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00657969</url>
  </required_header>
  <id_info>
    <org_study_id>CADISP</org_study_id>
    <nct_id>NCT00657969</nct_id>
  </id_info>
  <brief_title>Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections</brief_title>
  <acronym>CADISP</acronym>
  <official_title>Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cervical Artery Dissections and Ischemic Stroke Patients - Consortium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cervical Artery Dissections and Ischemic Stroke Patients - Consortium</source>
  <brief_summary>
    <textblock>
      The main purpose of this study is to look for genetic and environmental risk factors of&#xD;
      cervical artery dissections, a major cause of ischemic stroke in young adults, in a large&#xD;
      multicenter case-control trial&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Cervical artery dissections (CAD) are a major cause of ischemic stroke,&#xD;
      longstanding disability, and occasionally death in young adults. Several lines of evidence&#xD;
      suggest genetic predisposition for CAD. Previous genetic studies were, however, inconclusive&#xD;
      mainly due to insufficient numbers of patients. Our hypothesis is that CAD is a&#xD;
      multifactorial disease caused by yet largely unidentified genetic variants and environmental&#xD;
      factors, which may interact.&#xD;
&#xD;
      Aim: Our main aim is to look for genetic and environmental risk factors and gene-environment&#xD;
      interactions potentially underlying CAD. In addition, therapeutic aspects are addressed in&#xD;
      the setting of a multicenter registry.&#xD;
&#xD;
      Methods: We organized a multinational European network, CADISP (Cervical Artery Dissection&#xD;
      and Ischemic Stroke Patients) which targets at increasing our knowledge on the&#xD;
      pathophysiological mechanisms of this disease in a large, representative patient population.&#xD;
      Within this network, we are aiming to perform a de novo genetic association analysis using&#xD;
      both a genome-wide and a candidate gene approach. For this purpose, 1130 patients with CAD,&#xD;
      1130 patients with non-CAD ischemic stroke, and 1890 healthy controls are being recruited,&#xD;
      and detailed clinical, laboratory, diagnostic, therapeutic and outcome data are being&#xD;
      collected from all participating patients. We are expecting to reach the above numbers of&#xD;
      subjects by the end of 2008. Analyses of the CADISP database might clarify a number of&#xD;
      debated issues, including risk factors, stroke preventive treatment, and outcome predictors&#xD;
      of CAD.&#xD;
&#xD;
      We present the strategy of a collaborative project searching for genetic risk factors of&#xD;
      cervical artery dissections. We hope that the CADISP network will provide detailed and novel&#xD;
      data on risk factors and treatment aspects of CAD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2005</start_date>
  <completion_date type="Anticipated">September 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>association of genetic polymorphisms with cervical artery dissections</measure>
    <time_frame>2009</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>association of environmental risk factors with cervical artery dissections</measure>
    <time_frame>2009</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gene-environment interactions</measure>
    <time_frame>2009</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">4169</enrollment>
  <condition>Cervical Artery Dissection</condition>
  <condition>Stroke</condition>
  <condition>Brain Infarction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>CAD-group (Cervical Artery Dissection - group): consecutive patients with cervical artery dissection, with or without associated cerebral ischemia, hospitalized in one of the participating neurological centers; standardized inclusion and exclusion criteria apply</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>IS-group (Ischemic Stroke - Group): patients selected among consecutive patients hospitalized for an ischemic stroke without CAD, in the same centers as patients from group1, frequency-matched on age and gender with group1; standardized inclusion and exclusion criteria apply</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>HC-group (Healthy Control - Group): DNA of healthy individuals from existing DNA-databases will be used as controls for the Belgian, French, German and Swiss centers; the other centers are recruiting their own age- and sex-matched healthy controls; individuals from the 3 groups (CAD, IS and HC) are strictly matched on geographical origin in order to avoid stratification bias</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA, plasma, serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        groups 1 and 2: hospital-based, neurology departments group 3: community samples&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        GROUP1:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Typical radiological aspect of dissection* in a cervical artery (carotid and/or&#xD;
             vertebral);* Mural hematoma, pseudoaneurysm, long tapering stenosis, intimal flap,&#xD;
             double lumen, or occlusion &gt; 2 cm above the carotid bifurcation revealing a pseudo&#xD;
             aneurysm or a long tapering stenosis after recanalisation&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Purely intracranial dissection&#xD;
&#xD;
          -  Dissection occurring after an endovascular procedure&#xD;
&#xD;
          -  Known mendelian genetic disorder that can explain the dissection (e.g. vascular&#xD;
             Ehlers-Danlos syndrome)&#xD;
&#xD;
        GROUP2:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Recent ischemic stroke&#xD;
&#xD;
          -  No signs of CAD on extracranial duplex sonography and angiography (digital subtraction&#xD;
             or magnetic resonance or CT), performed &lt; 7 days after the stroke&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Possible cerebral ischemia but normal cerebral imaging&#xD;
&#xD;
          -  CAD cannot be ruled out (e.g.persistent arterial occlusion without mural hematoma)&#xD;
&#xD;
          -  Endovascular or surgical procedure on the coronary, cervical or cerebral arteries&#xD;
             during the 48 hours preceding the cerebral infarction&#xD;
&#xD;
          -  Cardiopathies with a very high embolic risk (Mechanical prosthetic valves, mitral&#xD;
             stenosis with atrial fibrillation, intracardiac tumor, infectious endocarditis,&#xD;
             myocardial infarction&lt;4 months)&#xD;
&#xD;
          -  Arterial vasospasm following a subarachnoid haemorrhage&#xD;
&#xD;
          -  Auto-immune disease possibly responsible for the cerebral infarction&#xD;
&#xD;
          -  Known monogenic disease responsible for the cerebral infarction&#xD;
&#xD;
        GROUP3:&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          -  Individuals from the general population without history of stroke, dissections in any&#xD;
             artery, transient ischemic attack, coronary artery disease, peripheral artery disease&#xD;
&#xD;
          -  Written informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>St√©phanie Debette, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Neurology (EA2691), University Hospital of Lille; Inserm, U744, Pasteur Institute, Lille, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Caspar Grond-Ginsbach, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Neurology, University Hospital of Heidelberg, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Didier Leys, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology (EA2691), University Hospital of Lille, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanatorio Allende</name>
      <address>
        <city>Cordoba</city>
        <zip>5000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Brussels (ULB)</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00290</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Besan√ßon</name>
      <address>
        <city>Besan√ßon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inserm U744 Institut Pasteur de Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital Piti√©-Salp√™tri√®re</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital Sainte-Anne</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rehabilitation Center, Schmieder-Klinik</name>
      <address>
        <city>Heidelberg</city>
        <zip>62120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Hospital of Ludwigshafen</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67063</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Munich</name>
      <address>
        <city>Munich</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>25100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Ospedale Maggiore Policlinico di Milano</name>
      <address>
        <city>Milano</city>
        <zip>20100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Milano San Raffaele</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital Milano-Bicocca</name>
      <address>
        <city>Monza</city>
        <zip>20052</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Perugia</name>
      <address>
        <city>Perugia</city>
        <zip>06081</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rehabilitation Center, IRCCS Santa Lucia, Roma</name>
      <address>
        <city>Rome</city>
        <zip>00100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neuroscience, St George's University Hospital of London</name>
      <address>
        <city>London</city>
        <zip>SW170RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Belgium</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Switzerland</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Engelter ST, Brandt T, Debette S, Caso V, Lichy C, Pezzini A, Abboud S, Bersano A, Dittrich R, Grond-Ginsbach C, Hausser I, Kloss M, Grau AJ, Tatlisumak T, Leys D, Lyrer PA; Cervical Artery Dissection in Ischemic Stroke Patients (CADISP) Study Group. Antiplatelets versus anticoagulation in cervical artery dissection. Stroke. 2007 Sep;38(9):2605-11. Epub 2007 Jul 26. Review.</citation>
    <PMID>17656656</PMID>
  </reference>
  <reference>
    <citation>Debette S, Metso TM, Pezzini A, Engelter ST, Leys D, Lyrer P, Metso AJ, Brandt T, Kloss M, Lichy C, Hausser I, Touz√© E, Markus HS, Abboud S, Caso V, Bersano A, Grau A, Altintas A, Amouyel P, Tatlisumak T, Dallongeville J, Grond-Ginsbach C; CADISP-group. CADISP-genetics: an International project searching for genetic risk factors of cervical artery dissections. Int J Stroke. 2009 Jun;4(3):224-30. doi: 10.1111/j.1747-4949.2009.00281.x.</citation>
    <PMID>19659826</PMID>
  </reference>
  <verification_date>October 2009</verification_date>
  <study_first_submitted>April 8, 2008</study_first_submitted>
  <study_first_submitted_qc>April 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2008</study_first_posted>
  <last_update_submitted>October 20, 2009</last_update_submitted>
  <last_update_submitted_qc>October 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. S Debette, Dr. C Grond-Ginsbach, Pr. D Leys</name_title>
    <organization>University Hospitals of Heidelberg and Lille</organization>
  </responsible_party>
  <keyword>Polymorphism, genetic</keyword>
  <keyword>Risk factors</keyword>
  <keyword>Carotid Artery, Internal, Dissection</keyword>
  <keyword>Vertebral Artery Dissection</keyword>
  <keyword>Genetic predisposition</keyword>
  <keyword>Outcome</keyword>
  <keyword>Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Infarction</mesh_term>
    <mesh_term>Aneurysm, Dissecting</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

